Clinical Trial Update: Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fludarabine with total body irradiation and post-transplant cyclophosphamide/tacrolimus GVHD prophylaxis (without mycophenolate mofetil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Ronald Paquette | Conditions: Hematologic Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING